This article is part of the PlexusDx Education Hub, our resource for evidence-based guidance on longevity protocols, peptide therapies, and the genetic variables behind every metabolic and aging-related decision
Hlebowicz, J., Hlebowicz, A., Lindstedt, S., Bjrgell, O., Hglund, P., Holst, J
There are five outcomes peptides will not deliver no matter which peptide is chosen, what the dose is, or how long the cycle runs
These patients were prescribed either a GLP-1 medication or another type of diabetes management medication and were observed for a dementia diagnosis within five years of starting the medication
500
Studies have shown that treating CRC cells with GLP-1RA can inhibit cell proliferation induced by insulin resistance by downregulating BMP4